{"id":"W4310961831","doi":"10.1158/1078-0432.ccr-22-1983","title":"Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; AstraZeneca","keywords":"Tremelimumab; Durvalumab; Hepatocellular carcinoma; Medicine; Oncology; Carcinoma; Internal medicine; Cancer; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003536084,0.0003316177,0.0007765545,0.000379515,0.0001478341,0.0005248087,0.0003893846,0.000366335,0.001404096],"category_scores_gemma":[0.004711732,0.0002284213,0.001480057,0.0003507737,0.0001907573,0.0004586324,0.0003446535,0.0007526511,0.0002676433],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009126959,"about_ca_system_score_gemma":0.0004847049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007816748,"about_ca_topic_score_gemma":0.0007774541,"domain_scores_codex":[0.9982992,0.0009628077,0.0001077767,0.0002915653,0.0002477872,0.00009092016],"domain_scores_gemma":[0.9970592,0.00153777,0.0008214512,0.0002755164,0.0001367132,0.0001694325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1041187,0.001996048,0.789499,0.000461277,0.006568663,0.0003596041,0.0003260978,0.01737687,0.01950195,0.000228918,0.0008109689,0.05875174],"study_design_scores_gemma":[0.002536579,0.02948711,0.8998443,0.00003279528,0.003125997,0.001135062,0.0001849353,0.0494777,0.01063312,0.0004896945,0.002986875,0.00006581103],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983323,0.0005468059,0.000520948,0.00005610249,0.000003967947,0.00003500844,0.0002405463,0.0000210938,0.0002432154],"genre_scores_gemma":[0.9993429,0.00006484046,0.0001932106,0.00003358952,0.000005585901,0.00002068157,0.00024048,0.000004430572,0.00009436031],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003536084,"threshold_uncertainty_score":0.01870084,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3085699116471894,"score_gpt":0.4517307875427443,"score_spread":0.1431608758955549,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}